These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8600791)

  • 1. Is keratoacanthoma a variant of squamous cell carcinoma. New insights into an old controversy ... soon?
    LeBoit PE
    Am J Dermatopathol; 1995 Aug; 17(4):319-20. PubMed ID: 8600791
    [No Abstract]   [Full Text] [Related]  

  • 2. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
    Lee YS; Teh M
    Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
    Ren ZP; Pontén F; Nistér M; Pontén J
    Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
    Helander SD; Peters MS; Pittelkow MR
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in formalin-fixed paraffin sections.
    Skálová A; Michal M
    Am J Dermatopathol; 1995 Aug; 17(4):332-4. PubMed ID: 8600794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
    Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
    Putti TC; Teh M; Lee YS
    Mod Pathol; 2004 Apr; 17(4):468-75. PubMed ID: 14976535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
    Filipowicz E; Adegboyega P; Sanchez RL; Gatalica Z
    Cancer; 2002 Feb; 94(3):814-9. PubMed ID: 11857317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases.
    Hodak E; Jones RE; Ackerman AB
    Am J Dermatopathol; 1993 Aug; 15(4):332-42; discussion 343-52. PubMed ID: 8214391
    [No Abstract]   [Full Text] [Related]  

  • 13. Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma.
    Ishitsuka Y; Kawachi Y; Taguchi S; Maruyama H; Nakamura Y; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
    Exp Dermatol; 2013 May; 22(5):318-22. PubMed ID: 23489647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma.
    Scola N; Segert HM; Stücker M; Altmeyer P; Gambichler T; Kreuter A
    Clin Exp Dermatol; 2014 Mar; 39(2):216-8. PubMed ID: 24524559
    [No Abstract]   [Full Text] [Related]  

  • 15. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
    Kerschmann RL; McCalmont TH; LeBoit PE
    Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses.
    McGregor JM; Farthing A; Crook T; Yu CC; Dublin EA; Levison DA; MacDonald DM
    J Am Acad Dermatol; 1994 May; 30(5 Pt 1):701-6. PubMed ID: 8176007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
    Connolly M; Narayan S; Oxley J; de Berker DA
    Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratoacanthoma: is it a real entity?
    Manstein CH; Frauenhoffer CJ; Besden JE
    Ann Plast Surg; 1998 May; 40(5):469-72. PubMed ID: 9600429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinic keratosis: time to call a spade a spade.
    Evans C; Cockerell CJ
    South Med J; 2000 Jul; 93(7):734-6. PubMed ID: 10923970
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative image analysis of p53 protein accumulation in keratoacanthomas.
    Borkowski A; Bennett WP; Jones RT; Borkowski P; Harris CC; Ferreira LR; Kao GF; Trump BF
    Am J Dermatopathol; 1995 Aug; 17(4):335-8. PubMed ID: 8600795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.